Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease.
about
Vitamin B12 in health and diseaseNitric oxide synthases in heart failureAsymmetric Dimethylarginine Is a Well Established Mediating Risk Factor for Cardiovascular Morbidity and Mortality-Should Patients with Elevated Levels Be Supplemented with Citrulline?Proteomic-based detection of a protein cluster dysregulated during cardiovascular development identifies biomarkers of congenital heart defectsPrelesional arterial endothelial phenotypes in hypercholesterolemia: universal ABCA1 upregulation contrasts with region-specific gene expression in vivoFolic acid treatment normalizes NOS-dependence of vascular tone in the metabolic syndrome.Novel strategies to ameliorate radiation injury: a possible role for tetrahydrobiopterinFolate intake and incidence of hypertension among American young adults: a 20-y follow-up studyDifferential modulation of nitric oxide synthases in aging: therapeutic opportunities.MicroRNAs and cardiovascular medicinePrevention of lethal murine pancreas ischemia reperfusion injury is specific for tetrahydrobiopterin.Folic acid supplementation at lower doses increases oxidative stress resistance and longevity in Caenorhabditis elegansMechanistic insights into folic acid-dependent vascular protection: dihydrofolate reductase (DHFR)-mediated reduction in oxidant stress in endothelial cells and angiotensin II-infused mice: a novel HPLC-based fluorescent assay for DHFR activity.Modulating endothelial nitric oxide synthase: a new cardiovascular therapeutic strategy.Why do homocysteine-lowering B vitamin and antioxidant E vitamin supplementations appear to be ineffective in the prevention of cardiovascular diseases?Lifestyle and metabolic approaches to maximizing erectile and vascular health.Tackling endothelial dysfunction by modulating NOS uncoupling: new insights into its pathogenesis and therapeutic possibilities.Folate, homocysteine and the cardiac neural crest.The role of homocysteine-lowering B-vitamins in the primary prevention of cardiovascular disease.Potential role of folate in pre-eclampsia.Folic Acid Promotes Recycling of Tetrahydrobiopterin and Protects Against Hypoxia-Induced Pulmonary Hypertension by Recoupling Endothelial Nitric Oxide SynthaseFolic acid reverses nitric oxide synthase uncoupling and prevents cardiac dysfunction in insulin resistance: role of Ca2+/calmodulin-activated protein kinase II.The prevalence and correlates of taking folic acid and vitamin supplements among adults aged ≥ 45 years with CVD.Multifactor dimensionality reduction analysis of MTHFR, PAI-1, ACE, PON1, and eNOS gene polymorphisms in patients with early onset coronary artery disease.Folic acid reduces doxorubicin-induced cardiomyopathy by modulating endothelial nitric oxide synthase.Folic acid may be a potential addition to diabetic foot ulcer treatment - a hypothesis.Folic acid ingestion improves skeletal muscle blood flow during graded handgrip and plantar flexion exercise in aged humans.Folic Acid and Homocysteine in Chronic Kidney Disease and Cardiovascular Disease Progression: Which Comes First?Impact of spinach consumption on DNA stability in peripheral lymphocytes and on biochemical blood parameters: results of a human intervention trial
P2860
Q24610264-BBA41D75-301D-4A7B-8BCC-281A23CAFBC0Q26830146-B0709DF5-B151-4189-B169-0EA43D835318Q28075206-CB653410-7DBA-419F-9D13-D22E118E901FQ28509745-95D80FC1-CD03-4EC7-B7BE-EADFD356A9A3Q33589194-7C403D7C-2067-4D16-BEC4-D4B8A8A163AEQ33701506-94D2E703-F152-4566-B7A0-17568AA5E3C2Q35848552-A710AEF1-F224-4481-91B1-D78ABAA3C87EQ35887605-E16766E2-F977-461B-B14F-164D617CDB66Q36056243-4765D950-F8E9-4436-AB2C-4B4112278297Q36165889-32123DFB-6195-4A3A-AFCF-11FFEF4AD84CQ36403729-8F62F6D9-E78A-4280-B098-C905BE3D2C26Q37219441-2F1F1256-611F-4C7A-9B3D-20C16E850D24Q37442791-442F9EE4-10AA-4C4A-BEDC-AD7E583B0ABCQ37881801-E190EDD5-0511-4572-8386-8716A83E1947Q37925013-C1EF4400-592F-4609-99B4-2114C524B2EBQ37954563-1827756D-EA33-4D2B-9D9E-EEA52B5C3861Q37968218-66327985-C9BB-40A0-88C6-CDBAEAE1C69EQ38075509-7EEA5C14-B5CF-4511-97B7-D477203A47F0Q38191275-C113ADA8-E2F1-4851-997F-F1A8AB75264BQ38584627-836EFEB5-0FFC-46FE-BC30-711F61907777Q41866231-D6BACF3F-085B-4440-8162-E2BA31BD5345Q42814641-6EE09A70-CCFA-4035-821E-232E4E34E069Q43144931-92B8E8C0-2F29-4D81-B515-8354ED234CF1Q44407761-D6A14E81-7F3E-4F4A-9DD1-2E21325409C7Q47115167-56F6E916-F792-443B-9884-AC88649B3C57Q47579229-7A7CC560-77EE-44A4-AC6C-0DA106AEB038Q48192505-79A7CBFE-6F59-4E6E-945F-44110E78F520Q50102454-8BD03DF3-714E-4CCA-BE97-4D0674FA215CQ57909803-6F9A5F70-AE2F-4898-9076-655E68843659
P2860
Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease.
@ast
Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease.
@en
Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease.
@nl
type
label
Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease.
@ast
Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease.
@en
Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease.
@nl
prefLabel
Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease.
@ast
Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease.
@en
Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease.
@nl
P2093
P1476
Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease.
@en
P2093
An L Moens
Christiaan J Vrints
David A Kass
Hunter C Champion
Jean-Pierre Timmermans
Marc J Claeys
P304
P356
10.1152/AJPHEART.91503.2007
P577
2008-03-28T00:00:00Z